Nav: Home

Heart-resident macrophages call in neutrophils following ischemic injury

August 04, 2016

Tissue injury, such as occurs in response to a lack of oxygen, promotes an influx of immune cells to the site of damage. After an ischemic injury to the heart, such as occurs after a heart attack or heart transplant, these responses are often maladaptive, resulting in decreased contractility and possible failure. Innate immune cells called neutrophils infiltrate the heart and are linked to pathogenic responses following an ischemic event; however, it is not clear how these cells are recruited to the site of damage. In this issue of JCI Insight, a team led by Daniel Kreisel of Washington University of Medicine determined that a macrophage population that resides in the heart promotes neutrophil recruitment in response to ischemic injury. Using a mouse heart transplant model of ischemic damage and live animal imaging, the authors determined that a subset of heart-resident macrophages that express a molecule known as CCR2 mediate neutrophil infiltration. Specifically, these macrophages produced molecules that attached neutrophils from the blood to the site of injury. Loss of CCR2 macrophages or blocking the production of neutrophil-attracting molecules reduced the numbers of neutrophils the migrated to the transplanted heart. Together, the results of this study reveal that resident macrophages provide signals that call neutrophils to the site of injury.
-end-
TITLE: Heart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling

AUTHOR CONTACT: Daniel Kreisel
Washington University in St. Louis
Email: kreiseld@wudosis.wustl.edu

View this article at:http://insight.jci.org/articles/view/87315?key=087e48230e1b57eefb01

JCI Insight is the newest publication from the American Society of Clinical Investigation, a nonprofit honor organization of physician-scientists. JCI Insight is dedicated to publishing a range of translational biomedical research with an emphasis on rigorous experimental methods and data reporting. All articles published in JCI Insight are freely available at the time of publication. For more information about JCI Insight and all of the latest articles go to http://www.insight.jci.org.

JCI Journals

Related Immune Cells Articles:

Immunology: How ancestry shapes our immune cells
A genetic variant that is particularly prevalent in people of African ancestry confers protection against malaria.
Immune cells derived from specialised progenitors
Dendritic cells are gatekeepers of Immunity. Up to now dendritic cell subtypes were thought to develop from one common progenitor.
Comprehensive atlas of immune cells in renal cancer
Researchers from the University of Zurich have individually analyzed millions of immune cells in tumor samples from patients with renal cell carcinoma.
When liver immune cells turn bad
A high-fat diet and obesity turn 'hero' virus-fighting liver immune cells 'rogue,' leading to insulin resistance, a condition that often results in type 2 diabetes, according to research published today in Science Immunology.
New role for immune cells in preventing diabetes and hypertension
Immune cells which are reduced in number by obesity could be a new target to treat diseases such as type 2 diabetes and hypertension that affect overweight people, according to a collaborative study between the University of Manchester, Lund University and the University of Salford.
Why male immune cells are from Mars and female cells are from Venus
Michigan State University researchers are the first to uncover reasons why a specific type of immune cell acts very differently in females compared to males while under stress, resulting in women being more susceptible to certain diseases.
Immune therapy scientists discover distinct cells that block cancer-fighting immune cells
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
Opioids produce analgesia via immune cells
Opioids are the most powerful painkillers. Researchers at the Charité -- Universitätsmedizin Berlin have now found that the analgesic effects of opioids are not exclusively mediated by opioid receptors in the brain, but can also be mediated via the activation of receptors in immune cells.
Oddly shaped immune cells cause fibrosis
Scientists at the Immunology Frontier Research Center (IFReC) at Osaka University, Japan, report a new group of monocytes they call SatM.
New system developed that can switch on immune cells to attack cancer cells
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.

Related Immune Cells Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".